| Volume 20 • Issue 10 |
May 13, 2020 |
|
|
|
|
 |
| |
MANAGING STRESS WHEN THE WORLD HAS COME TO A HALT
|
|
|
Helping pharmacists to learn a practical and integrated approach to coping and transcending challenging times. Watch our free webinar on-demand.
CLICK HERE
|
 |
|
|
 |
| |
prpdp-LevETIRAcetam ORAL SOLUTION 100 MG/ML NOW AVAILABLE IN CANADA
|
|
|
First oral solution of levetiracetam approved by Health Canada. The solution contains 100 mg/mL of levetiracetam and is available in bottles of 300 mL.
READ MORE
|
 |
|
|
 |
| |
INTRODUCING FULPHILA®
|
|
|
Mylan is proud to announce the availability of our second biosimilar in the Canadian marketplace.
READ MORE
FULPHILA® is a registered trademark of Mylan Institutional Inc., used under permission by BGP Pharma ULC, a Mylan company.
|
 |
|
|
 |
| |
UPCOMING KALETRA ORAL SOLUTION PACKAGING CHANGE
|
|
|
In coming months, the packaging for Kaletra Oral Solution (DIN #02243644) will undergo a minor change—the carton size will increase slightly.
READ MORE
|
 |
|
|
|
|
| |
PENTASA® AVAILABLE IN ORAL AND RECTAL FORMATS
|
|
|
PENTASA® is available in three distinct dosing forms. Consider PENTASA® for appropriate mild-to-moderate ulcerative colitis patients, and refer to the PENTASA® Product Monograph for further information.
READ MORE
|
 |
|
|
|
|
